Purdue Pharma, makers of the painkiller OxyContin, are going to seek U.S. Food and Drug Administration approval to label it for use by children as young as 6.
Oxycontin earned them $2.8 billion last year but drug companies have a tiny window in which they can make any money so they are always looking for creative ways to extend that. Even a 6-month extension is a billion bucks so Purdue is putting together a pediatric trial which will involve 154 children ages 6 to 16 that would finish in August, 2013.
Obviously for children in pain the ability of doctors to go 'off-label' is a good thing, but this isn't just about the kids. And the data on what an opiod could do to a very young brain basically does not exist.
PAINKILLERS FOR KIDS by Karen Keller, The Daily.com
Know Science And Want To Write?
Apply for a column: writing@science20.com
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
- China Sells Western Progressives Solar Panels While Switching To Nuclear Power
- On Rating Universities
- Gen Z Americans May Be Timid And Despondent About The Future But Not Gen Z Elsewhere
- If You Care About Earth Day, Stop Buying Organic, Fair Trade And Other Junk Stickers On Products
- Don't Buy Vietnamese Castor Oil Hemorrhoid Extract, Or Any Other Supplement
- Ozempic, Wegovy, and Mounjaro Have Helped The Rich Create New Healthcare Sneetch Stars
- Study: Caloric Restriction In Humans And Aging
Interesting insights from outside Science 2.0
Comments